Research
Hormonal
The majority of studies reported %FFML exceeding 25%.
Most patients on GLP-1RAs may experience a significant proportion of weight loss from fat-free mass.
StrongSupportsmedium confidence
the majority reported %FFML exceeding 25%.
Why this rating
Based on the analysis of 28 clinical trials.
Source
<scp>Glucagon‐like peptide</scp> ‐1 <scp>receptor agonist</scp> ‐based agents and weight loss composition: Filling the gaps
Robert L. Dubin et al. · Diabetes Obesity and Metabolism · 2024
reviewCited 35×
Read the paper This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →